Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Jeffrey Karp as a Venture Partner. The firm's profile page gives the current affiliation as Professor of Medicine, Harvard Medical School. His stated honours include inclusion in the MIT Technology Review 35 Innovators Under 35 (2008) and fellowship of the Royal Society of Chemistry and of the Biomedical Engineering Society (2018). Catalio's page lists him as a co-founder of Skintifique, Gecko Biomedical, Frequency Therapeutics, Alivio Therapeutics, Molecular Infusions, Landsdowne Laboratories and AltrixBio.